Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...
The FDA approved Endospan's Nexus aortic arch stent graft system, a bimodular device designed to mimic the ascending and arch ...
The wearable ECG monitors market is witnessing significant growth, poised to expand from $4.78 billion in 2025 to $5.9 billion in 2026, at a compound annu ...
Researchers at Mount Sinai have created an analytic tool using machine learning that they say can predict cardiovascular disease risk in millions of patients with obstructive sleep apnea, according to ...
Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK” or the "Company”) today announced that the results of a recently concluded VIVO study have been accepted in EP Europace, the leading European ...
In India’s $28 billion parenting market, startups are decoding every cry and blink. From AI cribs to cry-analysing apps, data ...
UCLA researchers have developed a dual-mode multiplexed vertical flow assay platform capable of detecting multiple cardiac ...
HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced a partnership with Inteleos(R) through its Point-of-Care Ultrasound (POCUS) ...
Oxford University researchers hope their tool will be rolled out across the NHS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results